Accelerate Diagnostics (AXDX) Competitors $0.70 -0.01 (-0.71%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$0.69 0.00 (-0.43%) As of 04/3/2025 05:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock AXDX vs. AKYA, OWLT, OMIC, PRE, OPTX, AATC, OPXS, CLIR, MSAI, and DAIOShould you be buying Accelerate Diagnostics stock or one of its competitors? The main competitors of Accelerate Diagnostics include Akoya Biosciences (AKYA), Owlet (OWLT), Singular Genomics Systems (OMIC), Prenetics Global (PRE), Syntec Optics (OPTX), Autoscope Technologies (AATC), Optex Systems (OPXS), ClearSign Technologies (CLIR), MultiSensor AI (MSAI), and Data I/O (DAIO). These companies are all part of the "measuring and control equipment" industry. Accelerate Diagnostics vs. Akoya Biosciences Owlet Singular Genomics Systems Prenetics Global Syntec Optics Autoscope Technologies Optex Systems ClearSign Technologies MultiSensor AI Data I/O Accelerate Diagnostics (NASDAQ:AXDX) and Akoya Biosciences (NASDAQ:AKYA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, community ranking, profitability, media sentiment, valuation, analyst recommendations, dividends and institutional ownership. Does the MarketBeat Community favor AXDX or AKYA? Accelerate Diagnostics received 320 more outperform votes than Akoya Biosciences when rated by MarketBeat users. Likewise, 59.07% of users gave Accelerate Diagnostics an outperform vote while only 58.33% of users gave Akoya Biosciences an outperform vote. CompanyUnderperformOutperformAccelerate DiagnosticsOutperform Votes35559.07% Underperform Votes24640.93% Akoya BiosciencesOutperform Votes3558.33% Underperform Votes2541.67% Do insiders & institutionals believe in AXDX or AKYA? 17.1% of Accelerate Diagnostics shares are held by institutional investors. Comparatively, 79.4% of Akoya Biosciences shares are held by institutional investors. 43.6% of Accelerate Diagnostics shares are held by insiders. Comparatively, 7.3% of Akoya Biosciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is AXDX or AKYA more profitable? Akoya Biosciences has a net margin of -66.77% compared to Accelerate Diagnostics' net margin of -471.83%. Accelerate Diagnostics' return on equity of 0.00% beat Akoya Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Accelerate Diagnostics-471.83% N/A -191.66% Akoya Biosciences -66.77%-162.99%-32.76% Do analysts recommend AXDX or AKYA? Akoya Biosciences has a consensus price target of $3.62, suggesting a potential upside of 196.45%. Given Akoya Biosciences' higher probable upside, analysts clearly believe Akoya Biosciences is more favorable than Accelerate Diagnostics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Accelerate Diagnostics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00Akoya Biosciences 0 Sell rating(s) 7 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more risk and volatility, AXDX or AKYA? Accelerate Diagnostics has a beta of 0.55, suggesting that its stock price is 45% less volatile than the S&P 500. Comparatively, Akoya Biosciences has a beta of 1.32, suggesting that its stock price is 32% more volatile than the S&P 500. Does the media prefer AXDX or AKYA? In the previous week, Akoya Biosciences had 2 more articles in the media than Accelerate Diagnostics. MarketBeat recorded 5 mentions for Akoya Biosciences and 3 mentions for Accelerate Diagnostics. Akoya Biosciences' average media sentiment score of 0.12 beat Accelerate Diagnostics' score of -0.50 indicating that Akoya Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Accelerate Diagnostics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative Akoya Biosciences 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has better earnings & valuation, AXDX or AKYA? Accelerate Diagnostics has higher earnings, but lower revenue than Akoya Biosciences. Akoya Biosciences is trading at a lower price-to-earnings ratio than Accelerate Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAccelerate Diagnostics$11.70M1.50-$61.62M-$2.34-0.30Akoya Biosciences$81.67M0.74-$63.32M-$1.13-1.08 SummaryAccelerate Diagnostics and Akoya Biosciences tied by winning 9 of the 18 factors compared between the two stocks. Remove Ads Get Accelerate Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for AXDX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AXDX vs. The Competition Export to ExcelMetricAccelerate DiagnosticsAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$17.52M$4.28B$5.54B$7.50BDividend YieldN/A0.54%4.86%4.04%P/E Ratio-0.2427.8023.2418.07Price / Sales1.504.18361.2586.83Price / CashN/A36.2438.1634.64Price / Book-0.511.606.493.99Net Income-$61.62M-$83.57M$3.21B$247.18M7 Day Performance-0.71%-5.69%-4.91%-4.25%1 Month Performance-34.74%-12.11%-0.08%-6.87%1 Year Performance-17.25%-36.79%6.40%-3.73% Accelerate Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AXDXAccelerate Diagnostics1.5371 of 5 stars$0.70-0.7%N/A-23.2%$17.52M$11.70M-0.24220Analyst ForecastGap UpHigh Trading VolumeAKYAAkoya Biosciences2.3247 of 5 stars$1.39-2.8%$3.62+160.2%-71.8%$69.24M$81.67M-1.1890OWLTOwlet2.7786 of 5 stars$3.67+2.5%$8.50+131.6%-11.3%$60.80M$78.06M-1.54106OMICSingular Genomics Systems0.6008 of 5 stars$20.01flat$6.50-67.5%N/A$50.83M$2.91M-0.57220PREPrenetics Global1.8469 of 5 stars$3.92-2.0%$9.00+129.6%+7.3%$47.84M$25.56M-0.981Upcoming EarningsShort Interest ↑Negative NewsOPTXSyntec Optics0.3824 of 5 stars$1.21-10.4%N/A-69.9%$44.40M$29.39M0.003Gap DownAATCAutoscope TechnologiesN/A$8.09-1.9%N/A+24.1%$44.34M$12.89M9.1940OPXSOptex Systems1.713 of 5 stars$5.68+1.4%N/A-17.7%$39.18M$35.23M9.3180Short Interest ↑News CoverageCLIRClearSign Technologies2.6099 of 5 stars$0.75-2.6%$6.00+700.0%-38.6%$37.68M$4.28M-6.8210Earnings ReportAnalyst ForecastMSAIMultiSensor AI3.1649 of 5 stars$0.93-17.0%$5.25+464.5%-67.0%$29.88M$7.62M0.0035Upcoming EarningsAnalyst ForecastNews CoverageGap DownDAIOData I/O2.0391 of 5 stars$2.45-2.4%$4.00+63.3%-30.5%$22.63M$21.77M-12.89100Gap Down Remove Ads Related Companies and Tools Related Companies AKYA Competitors OWLT Competitors OMIC Competitors PRE Competitors OPTX Competitors AATC Competitors OPXS Competitors CLIR Competitors MSAI Competitors DAIO Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AXDX) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Accelerate Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Accelerate Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AXDX Stock Free AXDX Stock Alerts